Shineco(US:SISI) Prnewswireยท2025-08-13 10:30Core Viewpoint - Shineco Inc. has established a Biological Cell Digital Business Division to integrate biological cell assets with blockchain technology, aiming to enhance the global distribution and sales of biological cell products [1][5]. Group 1: Division Objectives - The Division will utilize blockchain technology to create an efficient ecosystem for managing biological cell assets, focusing on standardized management, establishing an iPSC cell bank, and ensuring compliance for traceability [2]. - Key goals include developing blockchain tools for equity transfer to improve the efficiency of cell asset circulation [2]. Group 2: Benefits and Innovations - The Division is expected to allow medical and research institutions to allocate resources more flexibly and lower service access thresholds through flexible payment options [3]. - It aims to enhance collaboration across institutions, improve health data management, and introduce AI tools to optimize service experiences, making cell technology services more accessible globally [3]. Group 3: Leadership and Strategy - Mr. Lin Hongguang has been appointed as General Manager, bringing extensive experience in blockchain and digital assets, and will oversee strategic planning and operations of the Division [4]. - His responsibilities include developing standards for on-chain cell asset listings and expanding global collaborations to establish a distribution network for biological cell products [4]. Group 4: Industry Context - The bio-cell technology sector is identified as a key driver of the 'big health' industry, currently facing challenges such as low global circulation efficiency and high service thresholds [5]. - The establishment of the Biological Cell Digital Division is seen as a strategic investment to overcome these challenges and increase Shineco's market share in biological cell products [5].